News About: Pharm. Industry
53 drug firms sanctioned for kickbacks
The number of pharmaceutical companies receiving administrative measure on charge of illegal drug rebates totaled 53 over the past three years, a pharmaceutical information provider Yakup.com said Friday.
The punis...
Shin named as new Ipsen Korea head
Ipsen Korea has promoted its Korean office senior director Shin Hae-sung to lead the company as of March 12.
This is the first time that a global specialty-driven pharmaceutical company headquartered in France has ...
Drug makers grappling to survive
Local drug manufacturers are seeking ways to compete abroad as their profits continue to fall in the domestic market after comprehensive price cuts of drugs by the government last April.
Smaller companies are also ...
Eylea injection approved in Korea
Bayer HealthCare has recently received approval from the Korea Food and Drug Administration for Eylea (aflibercept) Injection for the treatment of wet age-related macular degeneration.
Eylea, known in the scientif...
Green Cross breaks ground for new plasma factory
Green Cross Corp. held a groundbreaking ceremony Wednesday in order to complete the construction of a plasma derivative plant in Bang Phra, 100 kilometers south of Bangkok, by the end of 2014.
Those participating i...
Local drug firms increase market share
With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.
According to Shinhan Inve...
Bayer Korea to transfer all of OTC products to Dong-A
Bayer Korea plans to transfer all of its over-the-counter medicines to Dong-A Pharmaceutical in a move to strengthen Bayer’s ethical business here.
“If the OTC transfer negotiation between the two companies are com...
Pharmaceutical firms’ operating profits halve
Local pharmaceutical companies saw a substantial setback in their performance last year, with operating profits more than halved compared to two years ago due to fallout from a dual punishment system, which introduced...
JW Medical eyes 105 billion won in sales
JW Medical, an affiliate of JW Holdings, has set its sights on 105 billion won in this year’s sales by 2015, its chief executive said Tuesday.
Chief executive officer (CEO) Noh Yong-gap said that JW Medical will se...
Handok donates 15,504 shares to employees
Handok Pharmaceutical said Monday it has donated a total of 15,504 shares, currently worth 323 million won, to its newly created employee stock ownership association after the company ended 48-year-long partnership wi...
